You just read:

US Gastroenterologists Report VARSITY Trial Data and JAK Inhibitor Safety Concerns Will Impact Their Prescribing Behavior in Ulcerative Colitis, with Potential Implications for Crohn's Treatment

News provided by

Spherix Global Insights

Jun 05, 2019, 17:16 ET